ProKidney Corp.
PROK
$2.28
$0.031.37%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 27.87% | 23.65% | 23.29% | 13.27% | -22.68% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 13.67% | 14.86% | 19.41% | 17.76% | -4.16% |
| Operating Income | -13.18% | -14.52% | -19.20% | -17.71% | 4.16% |
| Income Before Tax | -14.30% | -22.34% | -28.62% | -26.64% | 0.20% |
| Income Tax Expenses | 653.77% | -78.67% | -102.20% | -109.97% | -74.73% |
| Earnings from Continuing Operations | -16.60% | -19.59% | -23.97% | -20.59% | 1.24% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -3.03% | -6.93% | -1.07% | 2.17% | -10.85% |
| Net Income | -55.74% | -87.35% | -93.87% | -72.51% | -25.80% |
| EBIT | -13.18% | -14.52% | -19.20% | -17.71% | 4.16% |
| EBITDA | -12.73% | -13.89% | -18.51% | -17.10% | 5.23% |
| EPS Basic | 1.77% | 4.45% | -6.26% | -10.58% | 4.79% |
| Normalized Basic EPS | -144.96% | -122.40% | -104.46% | -78.28% | -44.51% |
| EPS Diluted | 1.77% | 4.45% | -6.26% | -10.58% | 4.79% |
| Normalized Diluted EPS | -144.96% | -122.40% | -104.46% | -78.28% | -44.51% |
| Average Basic Shares Outstanding | 60.80% | 97.26% | 84.25% | 56.59% | 30.48% |
| Average Diluted Shares Outstanding | 60.80% | 97.26% | 84.25% | 56.59% | 30.48% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |